Targanta Therapeutics' Unattributed VC Round

Targanta Therapeutics raised a round of funding on January 05, 2006. Investors include VenGrowth Capital Partners.

Targanta Therapeutics, Inc. (NASDAQ:TARG) is a biotechnology company developing and commercializing antibacterial drugs to treat serious infections in the hospital setting. Targanta's lead drug candid…

Articles about Targanta Therapeutics' Unattributed VC Round: